BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18337556)

  • 1. Nuclear translocation of urokinase-type plasminogen activator.
    Stepanova V; Lebedeva T; Kuo A; Yarovoi S; Tkachuk S; Zaitsev S; Bdeir K; Dumler I; Marks MS; Parfyonova Y; Tkachuk VA; Higazi AA; Cines DB
    Blood; 2008 Jul; 112(1):100-10. PubMed ID: 18337556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.
    Zhang L; Strickland DK; Cines DB; Higazi AA
    J Biol Chem; 1997 Oct; 272(43):27053-7. PubMed ID: 9341144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
    Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.
    Higazi AA; Upson RH; Cohen RL; Manuppello J; Bognacki J; Henkin J; McCrae KR; Kounnas MZ; Strickland DK; Preissner KT; Lawler J; Cines DB
    Blood; 1996 Jul; 88(2):542-51. PubMed ID: 8695802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin.
    Dumler I; Stepanova V; Jerke U; Mayboroda OA; Vogel F; Bouvet P; Tkachuk V; Haller H; Gulba DC
    Curr Biol; 1999 Dec 16-30; 9(24):1468-76. PubMed ID: 10607589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
    Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
    Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kringle stabilizes urokinase binding to the urokinase receptor.
    Bdeir K; Kuo A; Sachais BS; Rux AH; Bdeir Y; Mazar A; Higazi AA; Cines DB
    Blood; 2003 Nov; 102(10):3600-8. PubMed ID: 12881310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells.
    Song N; Ding Y; Zhuo W; He T; Fu Z; Chen Y; Song X; Fu Y; Luo Y
    Angiogenesis; 2012 Dec; 15(4):697-711. PubMed ID: 22711211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
    Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
    Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the single-chain urokinase-urokinase receptor complex activity by plasminogen and fibrin: novel mechanism of fibrin specificity.
    Higazi AA; Ajawi F; Akkawi S; Hess E; Kuo A; Cines DB
    Blood; 2005 Feb; 105(3):1021-8. PubMed ID: 15353482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.
    Chang AW; Kuo A; Barnathan ES; Okada SS
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1855-60. PubMed ID: 9848876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A; Kjøller L; Cohen RL; Lawrence DA; Garni-Wagner BA; Todd RF; van Zonneveld AJ; Gliemann J; Andreasen PA
    J Biol Chem; 1994 Oct; 269(41):25668-76. PubMed ID: 7929271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
    Tran H; Maurer F; Nagamine Y
    Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
    Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
    J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis.
    Mukhina S; Stepanova V; Traktouev D; Poliakov A; Beabealashvilly R; Gursky Y; Minashkin M; Shevelev A; Tkachuk V
    J Biol Chem; 2000 Jun; 275(22):16450-8. PubMed ID: 10749881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear targeting by the growth factor midkine.
    Shibata Y; Muramatsu T; Hirai M; Inui T; Kimura T; Saito H; McCormick LM; Bu G; Kadomatsu K
    Mol Cell Biol; 2002 Oct; 22(19):6788-96. PubMed ID: 12215536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor.
    Degryse B; Sier CF; Resnati M; Conese M; Blasi F
    FEBS Lett; 2001 Sep; 505(2):249-54. PubMed ID: 11566185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
    Conese M; Nykjaer A; Petersen CM; Cremona O; Pardi R; Andreasen PA; Gliemann J; Christensen EI; Blasi F
    J Cell Biol; 1995 Dec; 131(6 Pt 1):1609-22. PubMed ID: 8522616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.